Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EU’s CHMP Expected To OK Another Biosimilar Humira

Jun 22 2017

• By Ian Schofield

Jizo deities in Kamakura — • Source: Shutterstock

Related Content

Sandoz Files Biosimilar Humira & Remicade In EU; 13 Products Now Under Evaluation By CHMP

May 31 2017

Industry Bodies Warn Against Switching Among Biosimilars

Mar 10 2017

Setback For AbbVie’s Humira As English Court Decision Clears Way For Biosimilars

Mar 08 2017

Boehringer Ingelheim Limbering Up With Humira Biosimilar

Jun 14 2017

Biosimilar Launches Depend Mostly On Patents After Supreme Court Ruling

Jun 14 2017

13 Ways To Create A Sustainable Biosimilars Market In Europe

Sep 28 2016

Related Companies

AbbVie Inc.

Samsung Bioepis Co., Ltd.

Biogen, Inc.

Amgen, Inc.

Johnson & Johnson

Boehringer Ingelheim GmbH

Novartis AG

FUJIFILM Holdings Corp.

Additional Topics

Europe Biosimilars Approvals BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window